Home > Media Relations > Mercy News Archive

Media Relations: Mercy News Archive

HIPEC devices delivers heated chemotherapy into the patient's peritoneal cavity as part of cancer surgery

"HEAT IT TO BEAT IT," A Walk to Raise Awareness, Funds for Peritoneal Carcinamatosis, to be held Sept. 19th by Mercy's Institute for Cancer Care

Presented by the Institute for Cancer Care at Mercy Medical Center under the direction of renowned surgical oncologist Dr. Armando Sardi presents the "Heat It to Beat It" benefit walk to raise awareness and needed funds for the fight against Peritoneal Carcinamatosis.

The walk (2.8 mile course around the Inner Harbor) will be held on Sunday, Sept. 19th with registration at 9 a.m. and the walk starting at 10 a.m. at Baltimore's Rash Field.

Cost is $30 per walker (each walker will receive a premium t-shirt). This first benefit walk hopes to raise $50,000 (after expenses) for research in overcoming this disease.

The "Heat It To Beat It" refers to Dr. Sardi's pioneering work in the field of HIPEC or Hyperthermic (heated) Intraperitoneal Chemotherapy which has been found to be effective in treating severe abdominal cancers.

How to participate:
On-line registration will be available by June 1, 2010. Participants are encouraged to form teams and to walk in honor or memory of a loved one who has been affected by peritoneal carcinamatosis (PC). Teams which raise the most money will receive special recognition and thanks at the event.

Dr. Armando Sardi and the staff of the Institute for Cancer Care at Mercy

How to become an event sponsor:
Please contact Sarah Fawcett-Lee, Senior Director of Development at Mercy Medical Center: 410-332-9871 or sfawcett@mdmercy.com to receive a sponsor packet that includes a list of sponsorship opportunities and benefits, a sponsor commitment form, and literature about PC and Surgical Oncology at the Institute for Cancer Care at Mercy. Sponsorships are available at: $7,500 or higher (Presenting Sponsor); $5,000 (Blazing Hot Sponsor); $2,500 (Red Hot Sponsor); $1,000 (Steaming Hot Sponsor).

How to volunteer:
This event is a patient and family-led effort. We welcome you to join the volunteer committee by contacting Sarah Fawcett-Lee at 410-332-9871 or sfawcett@mdmercy.com.

What is peritoneal carcinamatosis?
Peritoneal carcinamatosis is a very rare and complex cancer, found in the abdominal cavity. Peritoneal carcinamatosis can be caused by tumors of the appendix, colon, rectum, ovary, stomach, and small bowel, and from primary peritoneal tumors and mesothelioma. Dr. Armando Sardi, director of the Institute for Cancer Care at Mercy, is a specialist in the treatment of this disease, performing over 50 heated intraperitoneal chemotherapy (HIPEC) surgeries per year.

How the proceeds will be used:
Proceeds from this event will support research conducted under the direction of Dr. Armando Sardi into the causes and treatment of peritoneal carcinamatosis. Dr. Sardi is one of the earliest practitioners of the universally accepted treatment protocol for patients with peritoneal carcinamatosis. His contribution to groundbreaking research and his advancement of cytoreductive surgery with HIPEC has increased survival rates for patients. Dr. Sardi and his colleagues work independently and in collaboration with other institutions world-wide, focusing on statistical analysis and extrapolation of individual patient demographic data, pharmaceutical efficacy studies and laboratory. The focus of all of these projects is centered on providing scientifically validated treatment protocols for patients world-wide, increasing the knowledge about peritoneal carcinamatosis, and discovering the physiological genesis and development of peritoneal tumors.